Performance of the DiaSorin LIAISON® anti-HBs II for the detection of hepatitis B surface antibodies: Comparison with the Abbott Architect anti-HBs assay

Journal of Clinical Virology

Volumn 50, Issue 4, 2011, Pages 297-302

  Kinn, Sophie ^a   Akhavan, Sepideh ^a   Agut, Henri ^a   Thibault, Vincent ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Evaluation; HBs antibody; Titration; WHO international standard

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANTIBODY TITER; ARTICLE; HEPATITIS B; HEPATITIS B SURFACE ANTIBODY ASSAY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL;

HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; SEROLOGIC TESTS;

EID: 79952625063     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.01.009     Document Type: Article

References (13)

1. Hepatitis B. Immunization surveillance, assessment and monitoring. 2010. (Accessed May 2010, at:). http://www.who.int/immunization_monitoring/diseases/hepatitis/en/index.html.
2. Hall A.J. Boosters for hepatitis B vaccination? Need for an evidence-based policy. Hepatology 2010, 51(5):1485-1486.
3. Papatheodoridis G.V., Cholongitas E., Archimandritis A.J., Burroughs A.K. Current management of hepatitis B virus infection before and after liver transplantation. Liver Int 2009, 29(9):1294-1305.
4. Roche B., Samuel D. Liver transplantation in viral hepatitis: prevention of recurrence. Best Pract Res Clin Gastroenterol 2008, 22(6):1153-1169.
5. Puro V., De Carli G., Cicalini S., Soldani F., Balslev U., Begovac J., et al. European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill 2005, 10(10):260-264.
6. Commission decision of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices. Official Journal of the European Communities 2002; L 131 (May 2002): 17-30.
7. Selby C. Interference in immunoassay. Ann Clin Biochem 1999, 36(Pt 6):704-721.
8. Huzly D., Schenk T., Jilg W., Neumann-Haefelin D. Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen. J Clin Microbiol 2008, 46(4):1298-1306.
9. Miedouge M., Legrand-Abravanel F., Lalanne C., Saune K., Izopet J. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers. J Clin Virol 2009, 44(2):134-137.
10. Motte A., Colson P., Tamalet C. Evaluation of the clinical performance of the Beckman Coulter Access AbHBsII immunoassay for the detection of hepatitis B surface antibodies. J Clin Virol 2006, 37(3):213-217.
11. Heijtink R.A., Schneeberger P.M., Postma B., Crombach W. Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100IU/l seroprotection levels unreliable. Vaccine 2002, 20(23-24):2899-2905.
12. Lada O., Benhamou Y., Poynard T., Thibault V. Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants. J Virol 2006, 80(6):2968-2975.
13. Terrault N., Roche B., Samuel D. Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective. Liver Transpl 2005, 11(7):716-732.